269 related articles for article (PubMed ID: 30385006)
1. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
Otter S; Whitaker S; Chatterjee J; Stewart A
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus and Associated Cancers: A Review.
Jensen JE; Becker GL; Jackson JB; Rysavy MB
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793561
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
5. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
Poljak M; Šterbenc A; Lunar MM
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in Germany attributable to human papillomavirus in 2013.
Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K
BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233
[TBL] [Abstract][Full Text] [Related]
7. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
8. [HPV: Carcinogenic implications and preventive measures].
Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
10. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.
Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA
Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
13. [Papillomavirus, could we speak about cancer and prevention?].
Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
[No Abstract] [Full Text] [Related]
14. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.
Giuliano AR; Nyitray AG; Kreimer AR; Pierce Campbell CM; Goodman MT; Sudenga SL; Monsonego J; Franceschi S
Int J Cancer; 2015 Jun; 136(12):2752-60. PubMed ID: 25043222
[TBL] [Abstract][Full Text] [Related]
15. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
16. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
18. The burden of HPV associated cancers in two regions in Nigeria 2012-2014.
Jedy-Agba EE; Dareng EO; Adebamowo SN; Odutola M; Oga EA; Igbinoba F; Otu T; Ezeome E; Bray F; Hassan R; Adebamowo CA
Cancer Epidemiol; 2016 Dec; 45():91-97. PubMed ID: 27780076
[TBL] [Abstract][Full Text] [Related]
19. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
de Sanjosé S; Bruni L; Alemany L
Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.
Brickman C; Palefsky JM
Curr HIV/AIDS Rep; 2015 Mar; 12(1):6-15. PubMed ID: 25644977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
